Key result
Enhanced External Counter Pulsation significantly improved blood pressure, heart rate, lipid profile, angina, and quality of life in both diabetic and non-diabetic CHD patients at 6 and 12 months.
Why the study?
The study was conducted to assess the effect of Enhanced External Counter Pulsation (EECP) on clinical parameters and health-related quality of life in coronary heart disease patients with diabetes mellitus.
Does Enhanced External Counter Pulsation (EECP) improve clinical parameters and health-related quality of life in coronary heart disease patients with and without diabetes mellitus?
Does Enhanced External Counter Pulsation (EECP) improve clinical parameters and health-related quality of life in coronary heart disease patients with and without diabetes mellitus?
EECP therapy is an effective non-invasive method that improves physical capacity, clinical parameters, and health-related quality of life in CHD patients with and without diabetes.
EECP was associated with improvements in CHD patients with or without diabetes; hypothesis-generating and requires randomized confirmation before practice change.
To assess the effect of Enhanced External Counter Pulsation (EECP) treatment on clinical parameters and health related quality of life (HRQoL) in Coronary Heart Disease (CHD) patients with Diabetes Mellitus. This was a pretest-posttest designed prospective study among 163 diabetic and non-diabetic coronary heart disease patients enrolled from SAAOL Heart Center, New Delhi, India. Patients were divided into two groups- diabetic CHD group and non-diabetic CHD group. EECP treatment was given to both the groups for 35 day. After EECP treatment physical and clinical profile along with HRQoL of study participants was assessed. The physical profile of study participants was assessed using Cooper’s 12 minutes’ walk test, Canadian Cardiovascular Society (CCS) angina scale and Medical Research Council (MRC) dyspnea scale and HRQoL was assessed through SF-36 (short form) and Seattle Angina Questionnaire (SAQ) scale. The follow-up of both groups was done at 6th and 12th months. Collected data were assessed through IBM, SPSS software v 21. Descriptive analysis with sample t-test for two independent groups and paired sample t-test for EECP effectiveness within the group was done. A significant improvement was observed in blood pressure; heart rate, lipid profile angina and MRC score in both the groups at 6th and 12 month follow-up. A significant reduction was observed in blood sugar fasting, blood sugar postprandial (PP) and glycosylated hemoglobin (HbA1c) in diabetic CHD patients. A significant improvement was also observed in all health domains of SF-36 & SAQ scale HRQoL after EECP treatment. EECP therapy is an effective non-invasive method to treat diabetic and non–diabetic CHD patients. This therapy may improve both physical (physical functional capacity, angina, dyspnea) and clinical profile (lipid profile, lower the blood glucose level) in diabetic CHD patients. EECP may also improve clinical symptoms of CHD patients and lower the blood glucose level in diabetic CHD patients this may directly improve overall HRQoL of CHD patients with DM.
No takes yet. Share an insight, caveat, or question.
Singh et al. (2019) studied Coronary Heart Disease with and without Diabetes Mellitus (n=163). Enhanced External Counter Pulsation (EECP) vs. Pre-treatment baseline and non-diabetic CHD patients was evaluated on Clinical parameters (blood pressure, heart rate, lipid profile, angina, dyspnea) and health-related quality of life (HRQoL). Enhanced External Counter Pulsation significantly improved blood pressure, heart rate, lipid profile, angina, and quality of life in both diabetic and non-diabetic CHD patients at 6 and 12 months.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: